P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans

Autor:	Kalra, A., Cote, S., Barrett, D., Long, K., Kavosi, M., Wawersik, S., Faulds, H., Treece, E., Iarrobino, R., Chyung, Y.
Zdroj:	In Neuromuscular Disorders October 2019 29 Supplement 1:S85-S85
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect